Clinical Trial Update: Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating prednisolone with a novel endpoint in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED